Advances in Cancer Treatment: Moving From a One‑Size‑Fits‑All Approach to Personalized Care

While experts remain cautious about using the word “cure,” cancer treatment has undergone a dramatic transformation over the past few decades.

New discoveries have made it possible to move away from a one‑size‑fits‑all approach—that is, one that uses the same treatment strategy for all cancer patients—and toward personalized therapies.

The effectiveness of these developments has led to higher survival rates, even though the number of cancer diagnoses is expected to increase.

According to a new report published in 2026 by the American Cancer Society, 70% of people diagnosed with cancer survive at least five years, up from 49% in the mid‑1970s.

People diagnosed with cancer that used to be fatal are now living much longer than they did in the mid‑1990s.

However, depending on the country, and even within the same country, disparities in access to care and treatment persist. As a result, the figures vary.

Progress in immunotherapy, gene editing, and early detection are three of the advances that have helped reshape survival curves in many cases.

Immuno‑oncology This field focuses on treatments that strengthen the immune system to fight cancer, including therapies such as CAR T‑cell therapy, which have shown promising results. Unlike chemotherapy, which destroys cells indiscriminately, immunotherapy helps the body's own immune system recognize cancer cells and produce antibodies to fight them.

Precision oncology This approach tailors treatment plans to the unique genetic profile of each patient's tumor, making therapies more effective and reducing side effects.

Early detection and diagnosis In addition to established screening methods such as mammograms and colonoscopies, new blood tests, including liquid biopsies, are being developed to detect cancer even before symptoms appear, dramatically increasing the chances of successful treatment.

These developments have helped make cancer a manageable disease. For many types of cancer, the goal is now to manage the disease as a chronic condition, enabling patients to live longer and enjoy a better quality of life.

One of the main reasons the term “cure” is used cautiously is that cancer isn't just one disease. It consists of more than 200 different diseases, some of which are more serious or harder to diagnose than others. Each cancer has unique genetic mutations that require different approaches to treatment.

In addition, cancer cells may develop resistance to treatment as they mutate. There's also the possibility of “recurrence,” the medical term for cancer returning after treatment. This is why people are often referred to as “cancer survivors” rather than “cured.”

Current research focuses on further studying and refining these advances, and even combining therapies. The goal is to improve the chances of long‑term remission, including for cancers that are particularly hard to treat.

Of course, lifestyle can greatly influence the development and incidence of cancer. Diet, tobacco use, and alcohol consumption, all remain modifiable risk factors for prevention.

Meanwhile, in labs, researchers are developing vaccines to help the immune system recognize and destroy tumor cells.

Artificial intelligence is also playing an increasingly prominent role in cancer treatment, helping researchers to analyze data and identify new treatment targets more quickly.